Abbott Laboratories Valuation
| ABL Stock | 92.17 0.60 0.65% |
At this time, the firm appears to be overvalued. Abbott Laboratories shows a prevailing Real Value of USD80.75 per share. The current price of the firm is USD92.17. Our model approximates the value of Abbott Laboratories from analyzing the firm fundamentals such as price to sales of 4.34 X, and Current Valuation of 164.97 B as well as examining its technical indicators and probability of bankruptcy.
Price Book 3.7511 | Enterprise Value 165 B | Enterprise Value Ebitda 18.9159 | Price Sales 4.3369 | Forward PE 19.3424 |
Overvalued
Today
Please note that Abbott Laboratories' price fluctuation is very steady at this time. Calculation of the real value of Abbott Laboratories is based on 3 months time horizon. Increasing Abbott Laboratories' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Abbott Laboratories' intrinsic value may or may not be the same as its current market price of 92.17, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 92.17 | Real 80.75 | Hype 92.17 | Naive 88.24 |
The intrinsic value of Abbott Laboratories' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Abbott Laboratories' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Abbott Laboratories helps investors to forecast how Abbott stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Abbott Laboratories more accurately as focusing exclusively on Abbott Laboratories' fundamentals will not take into account other important factors: Abbott Laboratories Cash |
|
About Abbott Laboratories Valuation
The stock valuation mechanism determines Abbott Laboratories' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Abbott Laboratories based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Abbott Laboratories. We calculate exposure to Abbott Laboratories's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Abbott Laboratories's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 26.7 B | 21.7 B |
Abbott Laboratories Quarterly Retained Earnings |
|
Additional Tools for Abbott Stock Analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.